Improving subchondral bone integrity reduces progression of cartilage damage in experimental osteoarthritis preceded by osteoporosis

Osteoarthritis and Cartilage

Volumn 19, Issue 10, 2011, Pages 1228-1236

  Bellido, M ^a   Lugo, L ^a   Roman Blas, J A ^a   Castaneda S ^a,b   Calvo, E ^c   Largo, R ^a   Herrero Beaumont, G ^a  

^a 28400 Madrid   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Cartilage damage; Osteoarthritis; Osteoporosis; PTH 1 34 ; Subchondral bone impairment

Indexed keywords

ALKALINE PHOSPHATASE; GELATINASE B; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE[1-34]; SODIUM CHLORIDE;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE REMODELING; BONE STRUCTURE; CARTILAGE INJURY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; HISTOPATHOLOGY; INJURY SEVERITY; KNEE SURGERY; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSTEOARTHRITIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SCORING SYSTEM; WESTERN BLOTTING;

ALKALINE PHOSPHATASE; ANIMALS; BONE REMODELING; CARTILAGE, ARTICULAR; CASE-CONTROL STUDIES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HINDLIMB; MATRIX METALLOPROTEINASE 9; OSTEOARTHRITIS, KNEE; OSTEOPOROSIS; OSTEOPROTEGERIN; PARATHYROID HORMONE; RABBITS; RANK LIGAND; X-RAY MICROTOMOGRAPHY;

EID: 80052960999     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2011.07.003     Document Type: Article

References (65)

1. Woolf A.D., Pfleger B. Burden of major skeletal conditions. Bull World Health Organ 2003, 81(9):646-656.
2. Bettica P., Cline G., Hart D.J., Meyer J., Spector T.D. Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study. Arthritis Rheum 2002, 46:3178-3184.
3. Day J.S., Ding M., van der Linden J.C., Hvid I., Sumner D.R., Weinans H. A decreased subchondral trabecular bone tissue elastic modulus is associated with pre-arthritic cartilage damage. J Orthop Res 2001, 19:914-918.
4. Pastoureau P.C., Chomel A.C., Bonnet J. Evidence of early subchondral bone changes in the meniscectomized guinea pig. A densitometric study using dual-energy X-ray absorptiometry subregional analysis. Osteoarthritis Cartilage 1999, 7:466-473.
5. Hayami T., Pickarski M., Zhuo Y., Wesolowski G.A., Rodan G.A., Duong le T. Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. Bone 2006, 38:234-243.
6. Hayami T., Pickarski M., Wesolowski G.A., McLane J., Bone A., Destefano J., et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum 2004, 50:1193-1206.
7. Botter S.M., van Osch G.J., Waarsing J.H., Day J.S., Verhaar J.A., Pols H.A., et al. Quantification of subchondral bone changes in a murine osteoarthritis model using micro-CT. Biorheology 2006, 43:379-388.
8. Intema F., Sniekers Y.H., Weinans H., Vianen M.E., Yocum S.A., Zuumond A.M., et al. Similarities and discrepancies in subchondral bone structure in two differently induced canine models of osteoarthritis. J Bone Miner Res 2010, 25:1650-1657.
9. Calvo E., Castañeda S., Largo R., Fernández-Valle M.E., Rodríguez-Salvanés F., Herrero-Beaumont G. Osteoporosis increases the severity of cartilage damage in an experimental model of osteoarthritis in rabbits. Osteoarthritis Cartilage 2007, 15:69-77.
10. Bellido M., Lugo L., Roman-Blas J.A., Castañeda S., Caeiro J.R., Dapia S., et al. Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis. Arthritis Res Ther 2010, 12. R152.
11. Radin E.L., Rose R.M. Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop Relat Res 1986, 213:34-40.
12. Neogi T., Nevitt M.C., Niu J., Sharma L., Roemer F., Guermazi A., et al. Subchondral bone attrition may be a reflection of compartment-specific mechanical load: the MOST Study. Ann Rheum Dis 2010, 69:841-844.
13. Neogi T., Felson D., Niu J., Lynch J., Nevitt M., Guermazi A., et al. Cartilage loss occurs in the same subregions as subchondral bone attrition: a within-knee subregion-matched approach from the Multicenter Osteoarthritis Study. Arthritis Rheum 2009, 61:1539-1544.
14. Dequeker J., Aerssens J., Luyten F.P. Osteoarthritis and osteoporosis: clinical and research evidence of inverse relationship. Aging Clin Exp Res 2003, 15:426-439.
15. Stewart A., Black A.J. Bone mineral density in osteoarthritis. Curr Opin Rheumatol 2000, 12:464-467.
16. Carbone L.D., Nevitt M.C., Wildy K., Barrow K.D., Harris F., Felson D., et al. Health, aging and body composition Study. The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. Arthritis Rheum 2004, 50:3516-3525.
17. Spector T.D., Conaghan P.G., Buckland-Wright J.C., Garnero P., Cline G.A., Beary J.F., et al. Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]. Arthritis Res Ther 2005, 7:R625-R633.
18. Bingham C.O., Buckland-Wright J.C., Garnero P., Cohen S.B., Dougados M., Adami S., et al. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 2006, 54:3494-3507.
19. Buckland-Wright J.C., Messent E.A., Bingham C.O., Ward R.J., Tonkin C. A 2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients. Rheumatology (Oxford) 2007, 46:257-264.
20. Karsdal M.A., Leeming D.J., Dam E.B., Henriksen K., Alexandersen P., Pastoureau P., et al. Should subchondral bone turnover be targeted when treating osteoarthritis?. Osteoarthritis Cartilage 2008, 16:638-646.
21. Goldring S.R., Goldring M.B. Bone and cartilage in osteoarthritis: is what's best for one good or bad for the other?. Arthritis Res Ther 2010, 12:143.
22. Sniekers Y.H., Weinans H., van Osch G.J., van Leeuwen J.P. Oestrogen is important for maintenance of cartilage and subchondral bone in a murine model of knee osteoarthritis. Arthritis Res Ther 2010, 12. R182.
23. Nielsen R.H., Bay-Jensen A.C., Byrjalsen I., Karsdal M.A. Oral salmon calcitonin reduces cartilage and bone pathology in an osteoarthritis rat model with increased subchondral bone turnover. Osteoarthritis Cartilage 2011, 19:466-473.
24. Ma H.L., Blanchet T.J., Peluso D., Hopkins B., Morris E.A., Glasson S.S. Osteoarthritis severity is sex dependent in a surgical mouse model. Osteoarthritis Cartilage 2007, 15:695-700.
25. Cake M.A., Appleyard R.C., Read R.A., Smith M.M., Murrell G.A., Ghosh P. Ovariectomy alters the structural and biomechanical properties of ovine femoro-tibial articular cartilage and increases cartilage iNOS. Osteoarthritis Cartilage 2005, 13:1066-1075.
26. Claassen H., Hornberger F., Scholz-Ahrens K., Schünke M., Schrezenmeir J., Kurz B. The effect of estrogens and dietary calcium deficiency on the extracellular matrix of articular cartilage in Göttingen miniature pigs. Ann Anat 2002, 184:141-148.
27. Oestergaard S., Sondergaard B.C., Hoegh-Andersen P., Henriksen K., Qvist P., Christiansen C., et al. Effects of ovariectomy and estrogen therapy on type II collagen degradation and structural integrity of articular cartilage in rats: implications of the time of initiation. Arthritis Rheum 2006, 54:2441-2451.
28. Castañeda S., Largo R., Calvo E., Bellido M., Gómez-Vaquero C., Herrero-Beaumont G. Effects of estrogen deficiency and low bone mineral density on healthy knee cartilage in rabbits. J Orthop Res 2010, 28:812-818.
29. Calvo E., Palacios I., Delgado E., Ruiz-Cabello J., Hernández P., Sánchez Pernaute O., et al. High-resolution MRI detects cartilage swelling at the early stages of experimental osteoarthritis. Osteoarthritis Cartilage 2001, 9:463-472.
30. Calvo E., Palacios I., Delgado E., Sanchez-Pernaute O., Largo R., Egido J., et al. Histopathological correlation of cartilage swelling detected by magnetic resonance imaging in early experimental osteoarthritis. Osteoarthritis Cartilage 2004, 12:878-886.
31. Hodsman A.B., Bauer D.C., Dempster D.W., Dian L., Hanley D.A., Harris S.T., et al. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev 2005, 26:688-703.
32. Lindsay R., Cosman F., Zhou H., Bostrom M.P., Shen V.W., Cruz J.D., et al. A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide. J Bone Miner Res 2006, 21:366-373.
33. Ma Y.L., Zeng Q., Donley D.W., Ste-Marie L.G., Gallagher J.C., Dalsky G.P., et al. Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis. J Bone Miner Res 2006, 21:855-864.
34. Jilka R.L., Weinstein R.S., Bellido T., Roberson P., Parfitt A.M., Manolagas S.C. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 1999, 104:439-446.
35. Canalis E., Giustina A., Bilezikian J.P. Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 2007, 357:905-916.
36. Yi W.J., Heo M.S., Lee S.S., Choi S.C., Huh K.H. Comparison of trabecular bone anisotropies based on fractal dimensions and mean intercept length determined by principal axes of inertia. Med Biol Eng Comput 2007, 45:357-364.
37. An H.S., Schwab J.P., Skrade D. Biological tissues and functional biomechanics. Synopsis of Orthopaedics 1992, 491-492. Thieme Medical Publishers Inc, New York. H.S. An (Ed.).
38. Bobinac D., Spanjol J., Zoricic S., Maric I. Changes in articular cartilage and subchondral bone histomorphometry in osteoarthritic knee joints in humans. Bone 2003, 32:284-290.
39. Lajeunesse D., Reboul P. Subchondral bone in osteoarthritis: a biologic link with articular cartilage leading to abnormal remodeling. Curr Opin Rheumatol 2003, 15:628-633.
40. Burr D.B. The importance of subchondral bone in osteoarthrosis. Curr Opin Rheumatol 1998, 10:256-262.
41. Seeman E., Delmas P.D. Bone quality - the material and structural basis of bone strength and fragility. N Engl J Med 2006, 354:2250-2261.
42. Jones M.D., Tran C.W., Li G., Maksymowych W.P., Zernicke R.F., Doschak M.R. In vivo microfocal CT and microMRI evaluation of antiresorptive and anti-inflammatory drugs as preventative treatments for osteoarthritis in the rat. Arthritis Rheum 2010, 62:2726-2735.
43. Kadri A., Funck-Brentano T., Lin H., Ea H.K., Hannouche D., Marty C., et al. Inhibition of bone resorption blunts osteoarthritis in mice with high bone remodelling. Ann Rheum Dis 2010, 69:1533-1538.
44. Sondergaard B.C., Oestergaard S., Christiansen C., Tankó L.B., Karsdal M.A. The effect of oral calcitonin on cartilage turnover and surface erosion in an ovariectomized rat model. Arthritis Rheum 2007, 56:2674-2678.
45. Manicourt D.H., Altman R.D., Williams J.M., Devogelaer J.P., Druetz-van Egeren A., Lenz M.E. Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions. Arthritis Rheum 1999, 42:1159-1167.
46. Behets C., Williams J.M., Chappard D., Devogelaer J.P., Manicourt D.H. Effects of calcitonin on subchondral trabecular bone changes and on osteoarthritic cartilage lesions after acute anterior cruciate ligament deficiency. J Bone Miner Res 2004, 19:1821-1826.
47. Ham K.D., Carlson C.S. Effects of estrogen replacement therapy on bone turnover in subchondral bone and epiphyseal metaphyseal cancellous bone of ovariectomized cynomolgus monkeys. J Bone Miner Res 2004, 19:823-829.
48. Roman-Blas J.A., Castañeda S., Largo R., Herrero-Beaumont G. Osteoarthritis associated with estrogen deficiency. Arthritis Res Ther 2009, 11:241.
49. Karsdal M.A., Byrjalsen I., Henriksen K., Riis B.J., Lau E.M., Arnold M., et al. The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study. Osteoarthritis Cartilage 2010, 18:150-159.
50. Howell D.S., Altman R.D., Pelletier J.-P., Martel-Pelletier J., Dean D.D. Disease modifying antirheumatic drugs: current status of their application in animal models of osteoarthritis. Osteoarthritic disorders 1995, 365-377. American Academy of Orthopedic Surgeons, Chicago. K.E. Kuettner (Ed.).
51. Kwan Tat S., Lajeunesse D., Pelletier J.P., Martel-Pelletier J. Targeting subchondral bone for treating osteoarthritis: what is the evidence?. Best Pract Res Clin Rheumatol 2010, 24:51-70.
52. Miyakoshi N., Kasukawa Y., Linkhart T.A., Baylink D.J., Mohan S. Evidence that anabolic effects of PTH on bone require IGF-I in growing mice. Endocrinology 2001, 142:4349-4356.
53. Bellido T., Ali A.A., Gubrij I., Plotkin L.I., Fu Q., O'Brien C.A., et al. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology 2005, 146:4577-4583.
54. Kulkarni N.H., Halladay D.L., Miles R.R., Gilbert L.M., Frolik C.A., Galvin R.J., et al. Effects of parathyroid hormone on Wnt signaling pathway in bone. J Cell Biochem 2005, 95:1178-1190.
55. Diarra D., Stolina M., Polzer K., Zwerina J., Ominsky M.S., Dwyer D., et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007, 13:156-163.
56. Kwan Tat S., Pelletier J.P., Lajeunesse D., Fahmi H., Lavigne M., Martel-Pelletier J. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells. Clin Exp Rheumatol 2008, 26:295-304.
57. Sakao K., Takahashi K.A., Mazda O., Arai Y., Tonomura H., Inoue A., et al. Enhanced expression of interleukin-6, matrix metalloproteinase-13, and receptor activator of NF-kappaB ligand in cells derived from osteoarthritic subchondral bone. J Orthop Sci 2008, 13:202-210.
58. Beyer C., Schett G. Pharmacotherapy: concepts of pathogenesis and emerging treatments. Novel targets in bone and cartilage. Best Pract Res Clin Rheumatol 2010, 24:489-496.
59. Chang J.K., Chang L.H., Hung S.H., Wu S.C., Lee H.Y., Lin Y.S., et al. Parathyroid hormone 1-34 inhibits terminal differentiation of human articular chondrocytes and osteoarthritis progression in rats. Arthritis Rheum 2009, 60:3049-3060.
60. Gomez Barrena E., Sanchez-Pernaute O., Largo R., Calvo E., Esbrit P., Herrero-Beaumont G. Sequential changes of parathyroid hormone related protein (PTHrP) in articular cartilage during progression of inflammatory and degenerative arthritis. Ann Rhem Dis 2004, 63:917-922.
61. Weisser J., Riemer S., Schmidl M., Suva L.J., Pöschl E., Bräuer R., et al. Four distinct chondrocyte populations in the fetal bovine growth plate: highest expression levels of PTH/PTHrP receptor, Indian hedgehog, and MMP-13 in hypertrophic chondrocytes and their suppression by PTH (1-34) and PTHrP (1-40). Exp Cell Res 2002, 279:1-13.
62. Moreno-Rubio J., Herrero-Beaumont G., Tardio L., Alvarez-Soria M.A., Largo R. Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis. Arthritis Rheum 2010, 62:478-488.
63. Anderson-MacKenzie J.M., Quasnichka H.L., Starr R.L., Lewis E.J., Billingham M.E., Bailey A.J. Fundamental subchondral bone changes in spontaneous knee osteoarthritis. Int J Biochem Cell Biol 2005, 37:224-236.
64. Dieppe P., Cushnaghan J., Young P., Kirwan J. Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis 1993, 52:557-563.
65. Herrero-Beaumont G., Roman-Blas J.A., Largo R., Berenbaum F., Castañeda S. Bone mineral density and joint cartilage: four clinical settings of a complex relationship in osteoarthritis. Ann Rheum Dis 2011, 70:1523-1525.